Granite Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $3.63M | Buy |
84,419
+75,669
| +865% | +$3.35M | 0.59% | 70 |
|
|
2021
Q2 | $343K | Sell |
8,750
-955
| -10% | -$37.1K | 0.05% | 148 |
|
|
2021
Q1 | $352K | Hold |
9,705
| – | – | 0.06% | 145 |
|
|
2020
Q4 | $357K | Sell |
9,705
-1,035
| -10% | -$38K | 0.06% | 139 |
|
|
2020
Q3 | $374K | Buy |
10,740
+1,868
| +21% | +$65.5K | 0.07% | 137 |
|
|
2020
Q2 | $275K | Buy |
8,872
+106
| +1% | +$3.6K | 0.06% | 138 |
|
|
2020
Q1 | $271K | Sell |
8,766
-298
| -3% | -$10.2K | 0.07% | 128 |
|
|
2019
Q4 | $337K | Sell |
9,064
-160
| -2% | -$5.7K | 0.06% | 136 |
|
|
2019
Q3 | $314K | Sell |
9,224
-1,097
| -11% | -$39.9K | 0.06% | 143 |
|
|
2019
Q2 | $424K | Sell |
10,321
-369
| -3% | -$14.7K | 0.08% | 121 |
|
|
2019
Q1 | $431K | Sell |
10,690
-2,877
| -21% | -$115K | 0.08% | 114 |
|
|
2018
Q4 | $562K | Sell |
13,567
-316
| -2% | -$13.1K | 0.12% | 109 |
|
|
2018
Q3 | $580K | Sell |
13,883
-527
| -4% | -$20.3K | 0.1% | 109 |
|
|
2018
Q2 | $496K | Sell |
14,410
-1,740
| -11% | -$59.5K | 0.09% | 112 |
|
|
2018
Q1 | $544K | Buy |
16,150
+1,990
| +14% | +$68.4K | 0.1% | 112 |
|
|
2017
Q4 | $487K | Buy |
14,160
+5,323
| +60% | +$182K | 0.09% | 123 |
|
|
2017
Q3 | $299K | Sell |
8,837
-264
| -3% | -$8.48K | 0.05% | 105 |
|
|
2017
Q2 | $286K | Buy |
9,101
+292
| +3% | +$9.21K | 0.05% | 107 |
|
|
2017
Q1 | $286K | Buy |
8,809
+1,688
| +24% | +$53.2K | 0.05% | 110 |
|
|
2016
Q4 | $219K | Sell |
7,121
-1,670
| -19% | -$51K | 0.04% | 114 |
|
|
2016
Q3 | $283K | Hold |
8,791
| – | – | 0.06% | 100 |
|
|
2016
Q2 | $294K | Hold |
8,791
| – | – | 0.06% | 100 |
|
|
2016
Q1 | $247K | Hold |
8,791
| – | – | 0.05% | 110 |
|
|
2015
Q4 | $269K | Hold |
8,791
| – | – | 0.06% | 113 |
|
|
2015
Q3 | $262K | Hold |
8,791
| – | – | 0.05% | 104 |
|
|
2015
Q2 | $280K | Hold |
8,791
| – | – | 0.05% | 108 |
|
|
2015
Q1 | $290K | Hold |
8,791
| – | – | 0.07% | 82 |
|
|
2014
Q4 | $260K | Hold |
8,791
| – | – | 0.06% | 80 |
|
|
2014
Q3 | $247K | Hold |
8,791
| – | – | 0.06% | 87 |
|
|
2014
Q2 | $248K | Hold |
8,791
| – | – | 0.05% | 87 |
|
|
2014
Q1 | $268K | Sell |
8,791
-5,349
| -38% | -$159K | 0.06% | 75 |
|
|
2013
Q4 | $411K | Sell |
14,140
-3
| -0% | -$87 | 0.09% | 68 |
|
|
2013
Q3 | $385K | Hold |
14,143
| – | – | 0.09% | 69 |
|
|
2013
Q2 | $376K | Buy |
+14,143
| New | +$391K | 0.09% | 66 |
|
Other funds holding PFE
Granite Investment Advisors's PFE Position: Q3 2021 in Review
Granite Investment Advisors increased its Pfizer (PFE) stake by 865% in Q3 2021, buying an estimated $3.35M and bringing the position to 84,419 shares worth $3.63M. The position accounts for 0.59% of the portfolio, ranked #70.
Granite Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 34 quarters since. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.
- Granite Investment Advisors held 84,419 shares of Pfizer worth $3.63M as of Q3 2021.
- Granite Investment Advisors bought 75,669 Pfizer shares in Q3 2021, an estimated $3.35M.
- Pfizer made up 0.59% of Granite Investment Advisors's portfolio in Q3 2021, its #70 holding.
- Granite Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 34 quarters since.
- 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.
Based on Granite Investment Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.